Stay updated on Baricitinib in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Baricitinib in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the Baricitinib in Adult Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check23 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. No substantive changes to study details, eligibility criteria, or locations were observed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check95 days agoChange DetectedRevision: v3.4.1 replaces the previous v3.4.0 revision. This is a metadata update that does not change study content or results.SummaryDifference0.0%

Stay in the know with updates to Baricitinib in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib in Adult Atopic Dermatitis Clinical Trial page.